Enzon Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net income was USD 0.197 million compared to net loss of USD 0.291 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0834 USD | -5.17% | +15.33% | -10.79% |
1st Jan change | Capi. | |
---|---|---|
-10.79% | 6.19M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ENZN Stock
- News Enzon Pharmaceuticals, Inc.
- Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023